2006
DOI: 10.1038/sj.cr.7310112
|View full text |Cite
|
Sign up to set email alerts
|

Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
102
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 110 publications
(106 citation statements)
references
References 9 publications
4
102
0
Order By: Relevance
“…Other studies have demonstrated that the caspase 9 inhibitor Z-LEHD-FMK (fluoromethylketone) prevented TRAIL-induced apoptosis in HCT116 cells (Ozoren et al, 2000;Kim et al, 2004). However, the selectivity of FMK-based small molecule caspase inhibitors (especially Z-LEHD-FMK) is highly debatable (Berger et al, 2006). We found that inhibiting caspase 9 activity using a more specific siRNA strategy failed to rescue apoptosis induced by FLIP siRNA in our panel of CRC cell lines.…”
Section: Discussionmentioning
confidence: 57%
“…Other studies have demonstrated that the caspase 9 inhibitor Z-LEHD-FMK (fluoromethylketone) prevented TRAIL-induced apoptosis in HCT116 cells (Ozoren et al, 2000;Kim et al, 2004). However, the selectivity of FMK-based small molecule caspase inhibitors (especially Z-LEHD-FMK) is highly debatable (Berger et al, 2006). We found that inhibiting caspase 9 activity using a more specific siRNA strategy failed to rescue apoptosis induced by FLIP siRNA in our panel of CRC cell lines.…”
Section: Discussionmentioning
confidence: 57%
“…In addition, we cannot exclude the possibility that the caspase-inhibitor cross reacts and blocks other matrix-degrading enzymes. 22 Because only low levels of cleaved caspase-3 are histologically detected on the cell membrane in vivo, we think that other matrix-degrading enzymes probably play a part in aneurysm progression. Even more, the number of elastic lamellear interruptions is considerably fewer than anticipated in the areas surrounding apoptotic SMCs.…”
Section: Discussionmentioning
confidence: 99%
“…2,[8][9][10][11] Unfortunately, most of them lack selectivity and cannot be used for selectively targeting or analyzing particular enzymes in complex biological environments. [12][13][14][15] This is entirely because of the overlapping specificities of the caspases on their preferred natural amino acid sequences. To address this problem we designed and synthesized a Hybrid Combinatorial Substrate Library (HyCoSuL) containing 19 natural amino acids (omitting cysteine) and 110 unnatural amino acids.…”
mentioning
confidence: 99%